From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
Allergy
; 77(3): 778-797, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34402066
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Eosinophilia
/
Asthma
/
Churg-Strauss Syndrome
/
Granulomatosis with Polyangiitis
/
Anti-Asthmatic Agents
Limits:
Humans
Language:
En
Journal:
Allergy
Year:
2022
Document type:
Article
Affiliation country:
United kingdom